NDC 67707-043-30 - Antara
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 67707-043
- Requested NDC
- 67707-043-30
- Package NDCs from labels
- 67707-043-30, 67707-043-99
- Manufacturer
- Oscient Pharmaceuticals Corporation
- Effective date
- 2008-01-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Antara - Oscient Pharmaceuticals Corporation | Oscient Pharmaceuticals Corporation | 2008-01-30 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67707-043-30 | Antara | 30 in 1 BOTTLE, PLASTIC | CAPSULE | 30 | 2 | |
| 67707-043-99 | Antara | 100 in 1 BOTTLE, PLASTIC | CAPSULE | 100 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| fenofibrate | ACTIVE INGREDIENT | U202363UOS | ANTARA (FENOFIBRATE) CAPSULE [OSCIENT PHARMACEUTICALS CORPORATION] | 2 | |
| fenofibrate | ACTIVE MOIETY | U202363UOS | ANTARA (FENOFIBRATE) CAPSULE [OSCIENT PHARMACEUTICALS CORPORATION] | 2 | |
| dimethicone | INACTIVE INGREDIENT | ANTARA (FENOFIBRATE) CAPSULE [OSCIENT PHARMACEUTICALS CORPORATION] | 2 | ||
| hypromellose | INACTIVE INGREDIENT | ANTARA (FENOFIBRATE) CAPSULE [OSCIENT PHARMACEUTICALS CORPORATION] | 2 | ||
| simethicone | INACTIVE INGREDIENT | ANTARA (FENOFIBRATE) CAPSULE [OSCIENT PHARMACEUTICALS CORPORATION] | 2 | ||
| sodium lauryl sulfate | INACTIVE INGREDIENT | 368GB5141J | ANTARA (FENOFIBRATE) CAPSULE [OSCIENT PHARMACEUTICALS CORPORATION] | 2 | |
| sugar spheres | INACTIVE INGREDIENT | ANTARA (FENOFIBRATE) CAPSULE [OSCIENT PHARMACEUTICALS CORPORATION] | 2 | ||
| talc | INACTIVE INGREDIENT | 7SEV7J4R1U | ANTARA (FENOFIBRATE) CAPSULE [OSCIENT PHARMACEUTICALS CORPORATION] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fenofibrate | FENOFIBRATE | Sun Pharmaceutical Industries, Inc. | 2083f5d9-92f2-4c64-b996-fabbd6946ea0 | 2026-06-19 | Warnings, Adverse reactions | 483425 483427 |
| Fenofibrate | FENOFIBRATE | PD-Rx Pharmaceuticals, Inc. | 2f5cee5c-ec55-4e9b-9d54-e7f2f052130e | 2026-02-26 | Warnings, Adverse reactions | 483425 |
| Fenofibrate | FENOFIBRATE | Apotex Corp. | 68024459-987a-9cf4-f539-4959093bc9f0 | 2025-10-29 | Warnings, Adverse reactions | 483425 483427 |
| ANTARA | FENOFIBRATE | Lupin Pharmaceuticals, Inc. | 24790a18-0291-4b88-a724-acac43b616ce | 2025-10-01 | Warnings, Adverse reactions | 483425 483427 578799 578797 |
| Fenofibrate | FENOFIBRATE | Lupin Pharmaceuticals, Inc. | 37b25526-0bd0-4459-a4be-f3a6893506f9 | 2025-06-02 | Warnings, Adverse reactions | 483425 483427 |
| Fenofibrate | FENOFIBRATE | Dr. Reddy's Laboratories Limited | 16ea8ce4-8c1c-4111-509e-86aa688d89a0 | 2018-12-28 | Warnings, Adverse reactions | 483425 483427 |
| 1F7FF2DA-E426-6A00-B6EC-0811C277E4B7 | ACCA05AB-185B-41A6-9CE2-783FC3C3CF96 | 2008-01-30 | Warnings, Adverse reactions | 1F7FF2DA-E426-6A00-B6EC-0811C277E4B7 ACCA05AB-185B-41A6-9CE2-783FC3C3CF96 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.